参考文献/References:
[1] FERENCE B A,GINSBERG H N,GRAHAM I,et al.Low-density lipoproteins cause atherosclerotic cardiovascular disease 1 evidence from genetic,epidemiologic,and clinical studies a consensus statement from the European Atherosclerosis Society Consensus Panel[J].Eur Heart J,2017,38(32):2459-2472.
[2] SABATINE M S,DE FERRARI G M,GIUGLIANO R P,et al.Clinical benefit of evolocumab by severity and extent of coronary artery disease[J].Circulation,2018,138(8):756-766.
[3] 中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南(2016年修订版)[J].中华心血管病杂志,2016,44(10):833-853.
[4] FERENCE B A,IAN G,LALE T,et al.Impact of lipids on cardiovascular health[J].J Am Coll Cardiol,2018,72(10):1141-1156.
[5] 王贺滋,韩雅玲,荆全民,等.青年冠心病危险因素与冠状动脉病变程度的相关性分析[J].解放军医学杂志,2011,36(4):24-28.
[6] ROBINSON J G,WILLIAMS K J,GIDDING S,et al.Eradicating the burden of atherosclerotic cardiovascular disease by lowering apolipoprotein b lipoproteins earlier in life[J].J Am Heart Assoc,2018,7(20):e009778.
[7] 程玥,王晞.新一代降脂药物PCSK9抑制药研究进展[J].医药导报,2018,37(2):178-182.
[8] NICHOLLS S J,BALLANTYNE C M,BARTER P J,et al.Effect of two intensive statin regimens on progression of coronary disease[J].N Engl J Med,2011,365(22):2078-2087.
[9] CATAPANO A L,GRAHAM I,DE BACKER G,et al.2016 ESC/EAS guidelines for the management of dyslipidaemias:the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR)[J].Atherosclerosis,2016,253:281-344.
[10] MILLER M,STONE N J,BALLANTYNE C,et al.Triglycerides and cardiovascular disease:a scientific statement from the American Heart Association[J].Circulation,2011,123(20):2292-2333.
[11] GENEROSO G,JANOVSKY C C P S.Triglycerides and triglyceri-de-rich lipoproteins in the development and progression of atherosclerosis[J].Curr Opin Endocrinol Diabetes Obes,2019,26(2):109-116.
[12] SNIDERMAN A D.ApoB in clinical care:Pro and Con[J].Atherosclerosis,2019,282:169-175.
[13] CARR S S,HOOPER A J,SULLIVAN D R.Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment[J].Pathology,2019,51(2):148-154.
[14] 左瑞平,张建军,韩常宝.脂蛋白(α)的生理功能及其与冠心病的研究进展[J].心脏杂志,2016,28(2):244-247.
[15] ZHOU B Y,SUN D,WANG C,et al.Plasma lipoprotein(a) concentration is associated with the coronary severity but not with events in stable coronary artery disease patients:a Chinese cohort study[J].Heart Lung Circ,2019,28(7):1009-1017.
相似文献/References:
[1]吕风华,张素荣,张跃光,等.冠状动脉粥样硬化性心脏病合并充血性心力衰竭患者血浆脑钠肽水平的检测[J].新乡医学院学报,2007,24(06):581.
[2]廖燕.老年冠状动脉粥样硬化性心脏病患者心功能与肺动脉压和心电指标的关系[J].新乡医学院学报,2012,29(09):696.
[3]郭鹏,李继红.不同类型冠状动脉粥样硬化性心脏病患者血浆D-二聚体和纤维蛋白原水平变化[J].新乡医学院学报,2012,29(09):698.
[4]李永锋,许志强,韩 鹏,等.冠状动脉粥样硬化性心脏病合并阻塞性睡眠呼吸暂停低通气综合征的临床分析 [J].新乡医学院学报,2012,29(10):784.
[5]舒 毅,陈幼萍,曾春平,等. 2型糖尿病合并冠状动脉粥样硬化性心脏病患者下肢血管病变相关因素分析[J].新乡医学院学报,2015,32(08):785.
[6]杨亚明,赵国安,冯春瑜,等.冠状动脉粥样硬化性心脏病患者的血脂代谢机制及药物治疗研究进展[J].新乡医学院学报,2021,38(10):996.[doi:10.7683/xxyxyxb.2021.10.020]
[7]许明发,王帅飞,苏国宝,等.不同血运重建方式治疗冠状动脉粥样硬化性心脏病合并左心室功能不全的早期疗效比较[J].新乡医学院学报,2018,35(11):1018.[doi:10.7683/xxyxyxb.2018.11.018]
XU Ming-fa,WANG Shuai-fei,SU Guo-bao,et al.Comparison of early outcomes of two kinds of revascularization on the patients with coronary heart disease complicated with left ventricular dysfunction[J].Journal of Xinxiang Medical University,2018,35(8):1018.[doi:10.7683/xxyxyxb.2018.11.018]
[8]欧红萍,李 彬,周凤勤.颈动脉超声检查联合血清超敏C 反应蛋白水平检测在冠状动脉粥样硬化性心脏病诊断中的应用[J].新乡医学院学报,2014,31(10):825.[doi:10.7683/xxyxyxb.2014.10.016]
[9]王 一.冠状动脉粥样硬化性心脏病合并二尖瓣疾病和心房颤动患者同期行冠状动脉搭桥联合二尖瓣置换术和双极射频消融术疗效观察[J].新乡医学院学报,2019,36(2):155.[doi:10.7683/xxyxyxb.2019.02.013]
WANG Yi.Clinical effect of coronary artery bypass grafting and mitral valve replacement and bipolar radiofrequency ablation on the patients with coronary atherosclerotic heart disease combined with mitral valve disease and atrial fibrillation[J].Journal of Xinxiang Medical University,2019,36(8):155.[doi:10.7683/xxyxyxb.2019.02.013]
[10]王 超,袁 宇.冠状动脉粥样硬化性心脏病患者肠道菌群丰度与血脂和血尿酸水平的相关性[J].新乡医学院学报,2019,36(7):623.[doi:10.7683/xxyxyxb.2019.07.006]
WANG Chao,YUAN Yu.Correlation between gut flora abundance and blood lipid,blood uric acid levels in patients with coronary atherosclerotic heart disease[J].Journal of Xinxiang Medical University,2019,36(8):623.[doi:10.7683/xxyxyxb.2019.07.006]